During the past decade, Queens Medical Associates conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 9 clinical trials were completed, i.e. on average, 225% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queens Medical Associates" #1 sponsor was "Hoffmann-La Roche" with 2 trials, followed by "Advanced Viral Research Corp" with 1 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queens Medical Associates" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "NYC Health & Hospitals/ Lincoln Medical Center" with 1 trials as a collaborator and "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Queens Medical Associates" are "Breast Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced Prostate Cancer" (1 trials), "Cancer" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Queens Medical Associates" in a lesser frequency.

Most popular intervention types in "Queens Medical Associates" are "Drug" (16 trials), "Biological" (2 trials), "Behavioral" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Rituximab" (2 trials), "docetaxel" (2 trials), "fluorouracil" (2 trials) and "paclitaxel" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queens Medical Associates" are 15 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Queens Medical Associates". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Queens Medical Associates, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Queens Medical Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".